Traffic at the Cognis Nutrition & Health booth at the SupplySide West trade show is expected to be brisk as dietary supplement and functional food manufacturers discover the benefits of three new, non-GMO natural health ingredients Cognis is launching — Covi-ox? T-95 EU natural mixed tocopherols, Vegapure? F40 WDP E water dispersible natural plant sterols, Xangold? 20% natural lutein ester beadlets.
A compromised immune system makes people more prone to contracting a cold or flu, and Cognis is helping companies meet the growing demand worldwide for immunity boosting dietary supplements and functional foods. Colds and flu are the most frequent infections across all age groups. Each year, Americans suffer from one billion colds, 100,000 are hospitalized and about 36,000 die from the flu and its complications. Immune health is also a global concern with frequent colds and flu ranked as one of the top three health problems by consumers in China, India and Latin America.
Alzheimer’s disease is an age-related progressive neurodegenerative disorder with an enormous unmet medical need. It is the most common form of dementia affecting 5% of adults over 65 years. In view of our ageing society the number of patients, as well as the economical and social impact, is expected to grow dramatically in the future. Currently available medications appear to be able to produce moderate symptomatic benefits but not to stop disease progression.
The King’s Centre for Military Health Research (KCMHR) has received further funding from the UK Ministry of Defence to continue its research into the health and well-being of military personnel, many of whom have served in Iraq. The research, which began in 2003 as a prospective investigation of the physical and psychological health of over 12,000 UK service personnel serving in Iraq, will be monitoring service personnel more widely, including those deployed to Afghanistan.
Proteins found in the blood can indicate an increased risk of Alzheimer’s disease, according to groundbreaking new research published today (30 October) in the journal Brain. It is the first time markers for the development of Alzheimer’s have been identified in blood. The findings take researchers a step closer to knowing whether a blood test can be used to diagnose and measure progression of the Alzheimer’s disease.
Rapid and guided healing of bones has moved a step closer with research by two biomedical engineering students who have found new ways to deliver bone growth enhancers directly to broken or weakened bones. Major ongoing research at Queensland University of Technology focuses on biodegradable materials that carry bone growth enhancing substances to encourage bones to heal quickly with much less intervention.
Little is known about socioeconomic differences in access to life-saving obstetric surgery, yet access to a caesarean for women is essential to achieve low levels of maternal mortality. “We examined population-based caesarean rates by socioeconomic groups in various developing countries” Carine Ronsmans PhD.
A test using cultured cells provides an effective way to screen drugs against Huntington’s disease and shows that two compounds ? memantine and riluzole ? are most effective at keeping cells alive under conditions that mimic the disorder, UT Southwestern Medical Center researchers report.
Osteoarthritis (OA) has a major impact on patients’ mobility and quality of life but the anti-inflammatory drugs used to treat it are associated with a number of side effects. In recent years, patients have turned increasingly to acupuncture to relieve the chronic pain associated with OA. A new study published in the November 2006 issue of Arthritis & Rheumatism examined the use of acupuncture as an extension of routine medical care and whether the effects of treatment last after therapy is discontinued.
The employee health department at Penn State Hershey Medical Center and Penn State College of Medicine plans several campus-wide vaccination days for any employee interested in receiving the flu shot. Vaccines will be given on a first-come, first-serve basis, starting Oct. 30.